Sign in

CIK 0000907654

  • Non-accelerated filer
  • Smaller reporting company

Oruka Therapeutics, Inc.

Sign in to watch
Ticker
ORKA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363855489
Phone
+1 650-606-7910
Business address
855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
Former names
ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 4 Open-market sale BRISTOW MICHAEL R sold 5,446 shares at $0.71 ($3,884)
  10. 4 Open-market sale VP, Finance sold 1,125 shares at $0.71 ($800)
  11. 4 Grant or award Chief Operating Officer acquired 25,350 shares (grant or award)
  12. 4 Derivatives Options or other derivatives
  13. 4 Grant or award S.V.P., General Counsel acquired 24,050 shares (grant or award)
  14. 4 Derivatives Options or other derivatives
  15. 4 Grant or award President and CEO acquired 48,100 shares (grant or award)
  16. 4 Grant or award VP, Finance acquired 23,400 shares (grant or award)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Open-market sale 10% owner sold 350,000 shares at an average $0.76 ($267,500)
  20. 4 Open-market sale 10% owner sold 550,000 shares at an average $0.92 ($503,500)

Page 12 of 23 · 459 filings